11:40 Jan 20

Norris Medicines Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
15.25
+0.49 (+3.32%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Norris Medicines Ltd. Financials

Norris Medicines Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
15.25
+0.49 (+3.32%)
11:40 Jan 20
Quality
image/svg+xml

0/100
Not Eligible

Valuation
image/svg+xml

15/100
Expensive Valuation

Technical

31/100
Technically Bearish

Strength

2

Weakness

8

Opportunity

0

Threats

0

-449.77 %

ROE %

-8.96 %

ROA %

0.00

EPS

-14.98

BVPS

0.00 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
12.25 9.44 8.36 5.64 5.82
Operating Expenses +
14 9.51 7.44 5.82 6.08
Raw Material
9.53 3.57 3.23 3.16 3.37
Increase Decrease in Cost
-0.79 2.04 0.13 -0.5 0.08
Other Manufacturing Expense
1.34 0 1.27 0 0
Employee Cost
3.1 2.33 2.3 1.82 1.41
Miscellaneous Expenses
0.82 1.57 0.51 1.34 1.22
Operating Profit
-1.75 -0.07 0.92 -0.18 -0.26
Other Income
0.05 0.03 0.01 0.03 0.06
Depreciation
0.67 0.66 0.63 0.57 0.54
Interest
1.63 1.48 1.5 0.37 0.44
Profit before tax and exceptio..
-3.99 -2.18 -1.19 -1.1 -1.18
Exceptional Items
0 0 0 0 0
PBT
-3.99 -2.18 -1.19 -1.1 -1.18
Provision for Taxation
0.97 1.08 0.56 0.09 0.06
Net Profit
-4.96 -3.26 -1.75 -1.19 -1.24
NET Profit after MI
0 0 0 0 0
EPS
-4.96 -3.26 -1.75 -1.19 -1.24
Operating Profit Margin (%)
-14.29 -0.74 11 -3.19 -4.47
Net Profit Margin (%)
-40.49 -34.53 -20.93 -21.1 -21.31

Norris Medicines Ltd. Shareholding

All Data in Percentage (%)

Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Promoter 34.00 34.00 34.00 34.00 34.00 34.00
FII 0.00 0.00 0.00 0.00 0.00 0.00
Public 0.10 0.10 0.10 0.10 0.10 0.10
Others 65.90 65.90 65.90 65.90 65.90 65.90
Shareholder Shares Holding %
Download Our App On: